Search Within

Isabelle C Riviere

Refine Results
Formats
  1. Meeting Abstract (90)
  2. Journal Article (69)
  3. Conference Paper (2)
Groups
  1. Sloan Kettering Institute Faculty (146)
  2. Center for Hematologic Malignancies (144)
  3. Molecular Pharmacology and Chemistry Program Faculty (142)
  4. Hematologic Malignancies Research (93)
  5. Hematologic Oncology, Division of (84)
  6. Adult Leukemia (72)

More Groups

People
  1. Michel Sadelain (142)
  2. Renier Brentjens (72)
  3. Xiuyan Wang (60)
  4. Jae Park (44)
  5. Shirley Bartido (26)
  6. Jolanta Stefanski (25)

More People

Years
  1. 2018 (14)
  2. 2017 (15)
  3. 2016 (10)
  4. 2015 (14)
  5. 2014 (15)
  6. 2013 (14)

More Years

Publications
  1. Blood (37)
  2. Molecular Therapy (36)
  3. Human Gene Therapy (10)
  4. Journal of Clinical Oncology (9)
  5. Haematologica (6)
  6. Nature Biotechnology (6)

More Publications

Publishers
  1. Nature Publishing Group (50)
  2. American Society of Hematology (37)
  3. American Society of Clinical Oncology (10)
  4. Mary Ann Liebert, Inc (10)
  5. Elsevier Inc. (9)
  6. American Association for Cancer Research (8)

More Publishers

Results (161)

Export to EndNote | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Phase I trial of autologous Cd19-targeted car-modified T cells as consolidation after purine analog-based first-line therapy in patients with previously untreated cll
    Meeting Abstract

    Park, J. H.; Riviere, I.; Wang, X.; Bartido, S.; Sadelain, M.; Brentjens, R. J.
    Haematologica (2014)

    Fulltext@MSK | Save
  • Genetic correction of differently mobilized hematopoietic stem cells from patients with thalassemia and engraftment kinetics after xenotransplantation
    Meeting Abstract

    Karponi, G.; Papayanni, P.; Lederer, C. W.; Psatha, N.; Zervou, F.; Zogas, N.; Tsatalas, C.; Anagnostopoulos, A.; Sadelain, M.; Riviere, I.; more...
    Haematologica (2014)

    Fulltext@MSK | Save
  • Engineered T Lymphocytes Expressing an Anti-Cd19 Car Specifically Eradicate B-Lymphoma Cells
    Meeting Abstract

    Tsukahara, T.; Ohmine, K.; Uchibori, R.; Urabe, M.; Mizukami, H.; Kume, A.; Riviere, I.; Sadelain, M.; Brentjens, R. J.; Ozawa, K.
    Journal of Gene Medicine (2014)

    Fulltext@MSK | Save
  • Development of inducible switch promoters that drive exogenous gene expression upon the recognition of CD19 by chimeric antigen receptors
    Meeting Abstract

    Uchibori, R.; Ninomiya, S.; Tsukahara, T.; Ido, H.; Teruya, T.; Omine, K.; Urabe, M.; Mizukami, H.; Kume, A.; Riviere, I.; more...
    Molecular Therapy (2014)

    Fulltext@MSK | Save
  • Efficient gene correction and engraftment of differently-mobilized human thalassemic CD34+cells
    Meeting Abstract

    Karponi, G.; Papayanni, P.; Lederer, C. W.; Psatha, N.; Zogas, N.; Zervou, F.; Kleanthous, M.; Anagnostopoulos, A.; Sadelain, M.; Riviere, I.; more...
    Molecular Therapy (2014)

    Fulltext@MSK | Save
  • Efficacy and toxicity management of 19-28z CAR T cell therapy in B cell acute lymphoblastic leukemia
    Meeting Abstract

    Brentjens, R.; Davila, M.; Riviere, I.; Wang, X. Y.; Bartido, S.; Park, J.; Bouhassira, D.; Curran, K.; Chung, S.; Stefanski, J.; more...
    Molecular Therapy (2014)

    Fulltext@MSK | Save
  • Safe mobilization of CD34+ cells in adults with β-thalassemia and validation of effective globin gene transfer for clinical investigation
    Journal Article

    Boulad, F.; Wang, X.; Qu, J.; Taylor, C.; Ferro, L.; Karponi, G.; Bartido, S.; Giardina, P.; Heller, G.; Prockop, S. E.; more...
    Blood (2014)

    Fulltext@MSK | Save
  • Efficacy and toxicity management of 19-28z CAR T cell therapy in B cell acute lymphoblastic leukemia
    Journal Article

    Davila, M. L.; Riviere, I.; Wang, X.; Bartido, S.; Park, J.; Curran, K.; Chung, S. S.; Stefanski, J.; Borquez-Ojeda, O.; Olszewska, M.; more...
    Science Translational Medicine (2014)

    Fulltext@MSK | Save
  • Chimeric antigen receptor (CAR(+)) modified T cells targeting prostate-specific membrane antigen (PSMA) in patients (pts) with castrate metastatic prostate cancer (CMPC)
    Meeting Abstract

    Slovin, S. F.; Wang, X.; Hullings, M.; Arauz, G.; Bartido, S.; Lewis, J. S.; Schoder, H.; Zanzonico, P.; Scher, H. I.; Sadelain, M.; more...
    Journal of Clinical Oncology (2013)

    Fulltext@MSK | Save
  • Chimeric antigen receptor (CAR(+)) modified T cells targeting prostate specific membrane antigen (PSMA) in patients (pts) with castrate metastatic prostate cancer (CMPC)
    Meeting Abstract

    Slovin, S. F.; Wang, X.; Hullings, M.; Arauz, G.; Bartido, S.; Lewis, J. S.; Schoder, H.; Zanzonico, P.; Scher, H. I.; Riviere, I.
    Journal of Clinical Oncology (2013)

    Fulltext@MSK | Save